Tratamento medicamentoso em miopatias autoimunes sistêmicas-Reference-Cited by-同舟云学术

Tratamento medicamentoso em miopatias autoimunes sistêmicas

Published:2017-12-31 Issue:2017 out-dez;16(4) Volume: Page:17-20
ISSN:2675-3898
Container-title:Revista Paulista de Reumatologia
language:pt
Short-container-title:Rev Paul Reumatol

Author:

Miossi Renata¹

Affiliation:

1. Médica-assistente. Membro do Ambulatório de Miopatias Inflamatórias e do Centro de Medicamentos de Alta Complexidade (CEDMAC) do Serviço de Reumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Abstract

Devido à raridade e heterogeneidade das miopatias autoimunes sistêmicas, há escassez de estudos robustos para definição de seu melhor tratamento. Assim sendo, o tratamento é basicamente guiado por estudos abertos ou retrospectivos, séries e relatos de caso. Em contrapartida, atualmente, há grande esforço para reverter essa situação, com a criação de critérios para a definição de resposta, subclassificações das doenças e estudos multicêntricos internacionais.

Publisher

Revista Paulista de Reumatologia

Reference54 articles.

1. Gordon PA, Winer JB, Hoogendijk JE, Choy EH. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev. 2012;(8):CD003643.

2. Leclair V, Lundberg IE. Recent clinical trials in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2017;29(6):652-9.

3. Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, et al.; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017;76(5):792-801.

4. Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, et al.; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2017;69(5):898-910.

5. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al.; International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017 Dec;69(12):2271-2282.